Reaction
Cytokine Storm reporting signals
As of the last recalculation, Cytokine Storm appears in 672 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 154.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 46 | 154.9 | 155.6 |
| Remdesivir | 16 | 38.1 | 38.1 |
| Cefepime Hydrochloride | 18 | 35.5 | 35.6 |
| Cefepime | 13 | 28.6 | 28.6 |
| Blinatumomab | 9 | 27.1 | 27.1 |
| Fludarabine Phosphate | 29 | 23.8 | 23.8 |
| Phenytoin | 14 | 21.2 | 21.2 |
| Meropenem | 21 | 20.9 | 20.9 |
| Norepinephrine | 7 | 20.5 | 20.5 |
| Ceftriaxone | 21 | 20.4 | 20.4 |
| Bendamustine Hcl | 10 | 20.3 | 20.3 |
| Anakinra | 10 | 18.9 | 18.9 |
| Nicotine Polacrilex Mini | 9 | 18.8 | 18.8 |
| Nicotine Polarilex | 9 | 18.8 | 18.8 |
| Norepinephrine Bitartrate | 8 | 17.4 | 17.4 |
| Pembrolizumab | 53 | 16.9 | 16.9 |
| Brentuximab Vedotin | 5 | 15.2 | 15.2 |
| Durvalumab | 9 | 13.9 | 13.9 |
| Lenvatinib | 14 | 13.5 | 13.5 |
| Ipilimumab | 18 | 13.2 | 13.2 |
| Oseltamivir | 3 | 11.7 | 11.7 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 9 | 11.7 | 11.7 |
| Benralizumab | 7 | 10.9 | 10.9 |
| Nivolumab | 30 | 10.0 | 10.0 |
| Cetuximab | 9 | 9.0 | 9.0 |
| Atezolizumab | 10 | 8.1 | 8.1 |